|
Video: What is a Stock Split?
|
|
CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. Co. is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck cancers, and Ligand Epitope Antigen Presentation System (LEAPS), with several product candidates under development for the potential treatment of rheumatoid arthritis. Multikine is a biological medicinal immunotherapy comprising a mixture of natural cytokines and small biological molecules. According to our CVM split history records, CEL-SCI has had 3 splits. | |
|
CEL-SCI (CVM) has 3 splits in our CVM split history database. The first split for CVM took place on May 01, 1995. This was a 1 for 10
reverse split, meaning for each 10
shares of CVM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. CVM's second split took place on September 25, 2013. This was a 1 for 10 reverse split, meaning for each 10 shares of CVM owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 10 share position following the split. CVM's third split took place on June 15, 2017. This was a 1 for 25 reverse split, meaning for each 25 shares of CVM owned pre-split, the shareholder now owned 1 share. For example, a 10 share position pre-split, became a 0.4 share position following the split.
When a company such as CEL-SCI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CVM split history from start to finish, an original position size of 1000 shares would have turned into 0.4 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CEL-SCI shares, starting with a $10,000 purchase of CVM, presented on a split-history-adjusted basis factoring in the complete CVM split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/11/2014 |
|
End date: |
12/09/2024 |
|
Start price/share: |
$14.00 |
|
End price/share: |
$0.64 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.43% |
|
Average Annual Total Return: |
-26.54% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$457.24 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
05/01/1995 | 1 for 10
| 09/25/2013 | 1 for 10 | 06/15/2017 | 1 for 25 |
|
|